We further uncover that through targeting EWS-Fli1, the BET bromodomain inhibitor JQ1 consequently modulates the expression level of the downstream EWS-Fli1 network genes in Ewing sarcoma cell lines and in in vivo tumor models. The gene discussed is FLI1; the disease is neoplasm.